T. Rowe Price Associates
PDLI

T. Rowe Price Associates’s PDL BioPharma, Inc. PDLI Stock Holding History

T. Rowe Price Associates’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-28,355
Closed -$89K – 2772
2020
Q3 		$89K Buy
+28,355
New +$89K ﹤0.01% 2513